Harvest Management’s UnitedHealth UNH Stock Holding History

Harvest Management’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,334	Closed	-$711K	–	76
2017 Q1	$711K	Buy	+4,334	New	+$710K	0.55%	33
2015 Q2	–	Sell	-5,000	Closed	-$591K	–	88
2015 Q1	$591K	Buy	+5,000	New	+$555K	0.64%	33

Other funds holding UNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Harvest Management's UNH Position: Q2 2017 in Review

Harvest Management sold out of UnitedHealth (UNH) in Q2 2017, closing a stake of 4,334 shares — an estimated $711K sold.

Harvest Management first reported a position in UNH in Q1 2015 and held it in 2 quarters. The position peaked at $711K in Q1 2017. 1,488 funds tracked by Wall St. Rank hold UNH as of Q2 2017.

Harvest Management reported no remaining UnitedHealth position as of Q2 2017 after selling out during the quarter.
Harvest Management sold 4,334 UnitedHealth shares in Q2 2017, an estimated $711K.
Harvest Management first reported a position in UnitedHealth in Q1 2015 and held it in 2 quarters.
Harvest Management's UnitedHealth position peaked at $711K in Q1 2017.
1,488 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2017.

Based on Harvest Management's 13F filing for Q2 2017, filed 11 Aug 2017.